Conservative Management of Breast Implant–Associated Infections: Identifying Risk Factors for Failure

Clicks: 1
ID: 316124
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #197 of 208 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 208 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Breast implant–associated infections remain a challenging complication, with limited high-quality evidence to guide management. Implant removal is often considered the standard approach, although conservative strategies aimed at implant salvage may be successful in selected patients. Methods We conducted a retrospective observational study of 42 patients diagnosed with breast implant–associated infection at a tertiary hospital between 2000 and 2024. All patients initially received antibiotic therapy without implant removal. Clinical, surgical, and microbiological variables were analyzed to identify predictors of treatment failure, defined as the need for implant removal. Logistic regression and Kaplan–Meier survival analyses were performed. Results Conservative management achieved infection control in 66.7% of patients, while 33.3% required implant removal. The most common symptoms were erythema (90.5%), pain (88.1%), and swelling (76.2%). Fistula was present in 33% and was strongly associated with treatment failure in univariable analysis (p=0.003), with a high odds ratio (7.5) in multivariable analysis. Elevated CRP and culture positivity correlated with poor outcomes. Staphylococcus aureus (36.8%) and Staphylococcus epidermidis (31.6%) were the most frequently isolated pathogens, although outcomes did not differ by microorganism. Kaplan–Meier analysis demonstrated a median failure-free survival of 191 months (almost 16 years), highlighting the potential long-term durability of conservative therapy in selected patients. Conclusions Conservative management may represent a valid therapeutic option for breast implant–associated infections in selected patients, particularly in the absence of fistula and persistent drainage. Prospective studies with larger cohorts and standardized protocols are needed to refine predictive models and establish evidence-based selection criteria for conservative therapy.
Reference Key
openalex_W7163764810 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Idoia Bilbao, María Pascual, Miguel Sogbe, Francisco Carmona-Torre, Trinidad Baselga, Manuel Pina, Iñigo Pineda, José Ramón Yuste, José Luís del Pozo
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag351
URL
https://doi.org/10.1093/ofid/ofag351
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.